My “Year of CBD” prediction is proving true fast, and this next prediction will really drive cannabis stocks higher.
When I predicted that 2019 would be the “Year of CBD,” I frankly didn’t expect it to unfold so quickly.
What started the year as a supplement sold only through websites and a handful of health and wellness-oriented stores can now be found on retail shelves nationwide.
Just four months into the year, CBD-infused products are being sold nationwide in shoe stores, malls, and major drug store chains.
And the CBD lineup at health and wellness stores continues to grow. MOM’s Organic Market, not too far from my house, went from only one product line to five in just a couple of months.
Here’s a photo I snapped just last week. In it, we’ve got products from Charlotte’s Web Holdings Inc. (CSE: CWEB, OTC; CWBHF), CV Sciences Inc. (OTC: CVSI), Emerald Health Therapeutics Inc. (TSXV: EMH, OTC: EMHTF), and two others.
And, just recently, GNC became another national chain adding CBD-infused topical creams to its shelves.
That’s why we set up a “Health and Wellness” subsector in our NICILytics database to let you identify our top CBD picks.
Up to this point, though, major retailers had only stocked CBD creams, balms, and salves that go on the skin.
These retailers haven’t stocked consumable CBD products yet, mostly because the U.S. Food and Drug Administration (FDA) hasn’t set clear rules about infusing foods and drinks with CBD.
Now, that’s not because they have concluded CBD should be regulated like a drug. It’s simply because they haven’t had time to write the final rules yet.
Moving Boldly Forward
Vitamin Shoppe Inc., one of the leading retailers of health and wellness products in the U.S., is adding CBD to the shelves of its stores in 14 states.
And we’re not just talking creams.
As soon as one critical catalyst strikes, these four pot stocks could shoot through the roof – and you could see a small stake turn into $100,000 or more. Before you miss your shot, get the inside story here.
The stores are going to be selling a line of CBD supplements. So, in addition to all the health and wellness boutiques selling CBD drops and capsules, one of the largest nutritional supplement purveyors in the country will stock their shelves with soft gels and soon liquid drops.
With this decision, this national retailer is flying in the face of FDA guidance. But they’re not doing so to spark controversy. Vitamin Shoppe isn’t looking to make a political statement or simply get some media attention.
They know what I know.
The FDA and CBD
Within months, the FDA will permit CBD to be added to food, beverage, and oral supplements without having to be approved as a drug. And when it does, investors in the right CBD stocks will cash in big time.
But with all the demands they receive from customers to offer CBD products, Vitamin Shoppe isn’t willing to lose out on sales while they wait for the FDA to make it legal.
Though Vitamin Shoppe’s move isn’t the only reason backing this prediction.
Based on recommendations made by the World Health Organization, CBD is about to get the green light throughout the free world. I fully expect the United Nations to act on that recommendation by the end of the year. When it does, CBD from any source will no longer be scheduled under any international drug control conventions.
So, knowing full well that the U.N. will make this move, the FDA isn’t about to write rules that will in short order be contradicted by the U.N. – especially one witnessing such strong growth in consumer demand.
Now, to be sure, the FDA will not allow CBD supplements to be sold with unsubstantiated health claims. To market a product as a treatment for specific conditions, the FDA will exercise its authority to regulate those products as a drug and subject them to the same processes as all other drugs, including clinical trials.
But for general health and wellness uses, they won’t get in the way. By the end of summer, the FDA will have written rules clarifying its position and giving large retailers across the U.S. the green light to sell CBD-infused products, and the race to dominate the market will shift into high gear.
Executive Director, National Institute for Cannabis Investors
P.S. Cannabis just hit its perfect “sweet spot.” According to our experts, cannabis just entered “Phase 2.” You see, the rapid consolidation we’ve seen in the market could lead to life-changing profits for the investors smart enough to move in now. The writing is on the wall. That means… You can still stake your claim in some of the firms for fractions of what they could be worth weeks or months from now. The next generation of potential billion-dollar cannabis companies is ripe for the picking. You just have to make smart moves. And if you click here, we can show you four moves you need to consider right now, before it’s too late.
17 responses to ““The Year of CBD” Has Led to Yet Another Profit-Boosting Prediction”
April 29 2019